ahlam1399
08-22-2016, 04:17 AM
Pfizer nears deal to acquire Medivation for close to $14 billion
(Reuters) - Pfizer Inc is in advanced talks to acquire U.S. cancer drug company Medivation Inc for close to $14 billion, as it seeks to boost its oncology portfolio, people familiar with the matter said on Sunday.http://feeds.feedburner.com/~ff/reuters/businessNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/businessNews?a=W0Nf7P-1KwE:bOE4c8UiMbo:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/businessNews?i=W0Nf7P-1KwE:bOE4c8UiMbo:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/businessNews?a=W0Nf7P-1KwE:bOE4c8UiMbo:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/businessNews?i=W0Nf7P-1KwE:bOE4c8UiMbo:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/businessNews?a=W0Nf7P-1KwE:bOE4c8UiMbo:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/businessNews/~4/W0Nf7P-1KwE
(Reuters) - Pfizer Inc is in advanced talks to acquire U.S. cancer drug company Medivation Inc for close to $14 billion, as it seeks to boost its oncology portfolio, people familiar with the matter said on Sunday.http://feeds.feedburner.com/~ff/reuters/businessNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/businessNews?a=W0Nf7P-1KwE:bOE4c8UiMbo:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/businessNews?i=W0Nf7P-1KwE:bOE4c8UiMbo:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/businessNews?a=W0Nf7P-1KwE:bOE4c8UiMbo:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/businessNews?i=W0Nf7P-1KwE:bOE4c8UiMbo:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/businessNews?a=W0Nf7P-1KwE:bOE4c8UiMbo:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/businessNews/~4/W0Nf7P-1KwE